Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lipitor's dosage change cause liver enzyme fluctuations?Campath litigation germany?Drug patent watch trametinib?What's the advised delay for milk post lipitor?How does paclitaxel's binding to albumin change its pharmacokinetics?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its first FDA approval in October 2014 [1].
The month/year above refers to Keytruda’s initial FDA approval (not later label expansions or new indication approvals). Sources: [1] https://www.drugpatentwatch.com/p/biologics/keytruda
Other Questions About Keytruda :